What does U.S. — total segment and consolidated revenue mean?

This metric represents the total net revenue generated from customers located within the United States, excluding any assessed taxes. It serves as a key indicator of the company's commercial footprint and market penetration within the U.S. healthcare sector for its portfolio of immunology and infectious disease therapies. Tracking this figure allows investors to evaluate the geographic concentration of sales and the effectiveness of domestic commercialization strategies.

Vir Biotechnology, Inc. VIR U.S. — Total segment and consolidated revenue

Similar metrics at other companies

AZTAUnited States — Total Revenue

$83.02M-7.7%

CDNAUnited States — Total Revenue

$113.65M+42.3%

DLBUnited States — Total Revenue

$220.05M+36.2%

REYNUnited States — Total segment net revenues

$907.75M+0.8%

WKUnited States — Total Revenue

$176.32M+14.1%

EXELU.S. — Total revenues

$558.55M+8.0%

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.68B+61.1%

Enterprise value$1.49B+102%

P/S25.6×-24.3×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept vir:RevenueFromContractWithCustomerExcludingAssessedTaxNet.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s u.s. — total segment and consolidated revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s U.S. — total segment and consolidated revenue?: Vir Biotechnology, Inc. (VIR) reported U.S. — total segment and consolidated revenue of $12K in Q1 2026.
What does U.S. — total segment and consolidated revenue mean?: This metric represents the total net revenue generated from customers located within the United States, excluding any assessed taxes. It serves as a key indicator of the company's commercial footprint and market penetration within the U.S. healthcare sector for its portfolio of immunology and infectious disease therapies. Tracking this figure allows investors to evaluate the geographic concentration of sales and the effectiveness of domestic commercialization strategies.